Companies
- Companies
- Company details
Auxilium Pharmaceuticals Inc
Out-licensing
Phase I Clinical Development of an Oxybutynin Transmucosal Film Product: Treatment of Overactive Bladder More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2010 - 26 pages - $99
Aug 2010 - 21 pages - $125
Nov 2010 - 40 pages - $500
Mar 2011 - 39 pages - $125
Jun 2011 - 46 pages - $125
Nov 2007 - 47 pages - $495
Jan 2010 - $75
May 2011 - 42 pages - $125
Nov 2010 - 65 pages - $600
Feb 2011 - 40 pages - $125
Contact details
Mr. Rami Daoud
Director
Business Development
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us